Jun 10, 2026
Partners met to review progress and align on next steps
The iPROLEPSIS consortium held its 8th Plenary Meeting on 8–9 June 2026 in Athens, Greece, hosted by project partners DBC and Ainigma Technologies. Partners reviewed the project's latest progress and aligned on priorities for the coming months.
Over two days, the consortium discussed updates across all active areas of the project – from data harmonisation and predictive modelling to clinical study status, platform development, and dissemination and communication activities. Progress on exploitation and regulatory planning was also presented.
An External Advisory Board (EAB) session was held, where board members reviewed key project results and provided scientific and strategic feedback.
The plenary concluded with a summary of agreed actions and priorities. Partners will focus on advancing the clinical studies, continuing development of the iPROLEPSIS ecosystem, progressing scientific work on digital biomarkers and predictive models, and delivering the next planned milestones and deliverables.
